|
Search
Collections
Benchmarks
Upload document
Organization
CIML
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 abstract
Abstract
Preclinical assessment of IPH6501, a first-in-class IL2v-armed tetraspecific NK cell engager directed against CD20 for R/R B-NHL, in comparison with a CD20-targeting T cell engager.
Org:
CIML,